America’s Blood Centers (ABC) submitted these formal comments to the Food and Drug Administration (FDA) in response to a draft guidance on responding to FDA Form 483 observations at the conclusion of a drug CGMP inspection.
ABC supports FDA’s draft guidance on responding to Form 483 observations and appreciates its focus on effective corrective actions and blood sup...